A detailed history of Baystate Wealth Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Baystate Wealth Management LLC holds 507 shares of DXCM stock, worth $35,231. This represents 0.0% of its overall portfolio holdings.

Number of Shares
507
Holding current value
$35,231
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

BUY
$75.49 - $124.16 $38,273 - $62,949
507 New
507 $62,000
Q2 2022

Aug 02, 2022

BUY
$67.99 - $132.89 $0 - $0
0 New
0 $0

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $26.8B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Baystate Wealth Management LLC Portfolio

Follow Baystate Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baystate Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baystate Wealth Management LLC with notifications on news.